-
Podophyllotoxin Workflows for Cancer Research
2026-09-03
Podophyllotoxin provides a practical microtubule-based perturbation for studying mitotic arrest, apoptosis, autophagy, and drug resistance. This workflow shows how to prepare the reagent, distinguish parent-compound effects from podophyllotoxin-derivative findings, and troubleshoot concentration, flux, and mechanism assays.
-
AZD1480: Blocking the IL-6–JAK2–STAT3 Escape Loop
2026-09-02
AZD1480 provides a mechanistically focused way to test whether tumor-intrinsic JAK2/STAT3 signaling enables cancer-cell survival after IDO1 inhibition. This thought-leadership analysis connects immune-metabolic biology, pathway pharmacology, assay design, and translational strategy while defining the opportunities and limitations of combination studies.
-
Ibrexafungerp (MK 3118): Mechanism & Evidence
2026-09-02
Ibrexafungerp, also known as MK 3118, is an oral triterpenoid glucan synthase inhibitor with activity against resistant Candida, including Candida auris. Peer-reviewed murine data support delayed-treatment efficacy, while FDA labeling limits established clinical use to vulvovaginal candidiasis and recurrent vulvovaginal candidiasis prevention.
-
Y-27632 Dihydrochloride in Gut Chips
2026-09-01
Y-27632 dihydrochloride is a selective ROCK inhibitor that can help researchers distinguish cytoskeletal effects from genuine neuro-epithelial signaling in gut-on-chip assays. This guide translates a compartmentalized microfluidic gut model into practical decisions about controls, timing, imaging, and interpretation.
-
Necrosulfonamide Workflows for MLKL Studies
2026-09-01
Necrosulfonamide provides a practical way to separate MLKL-driven membrane failure from upstream phosphorylation and unrelated apoptosis. This workflow connects dose-response necroptosis assays with mechanistic cardiac ischemia–reperfusion models, cancer research, and carefully qualified disease-model applications.
-
28S rRNA Expansion Segments Build Nucleolar Layers
2026-08-31
Wei and colleagues show that 28S rRNA expansion segments act as multivalent architectural modules that help establish multilayered nucleolar organization. Cross-species reconstitution, targeted deletions, segment transfer, and simulations connect evolutionary RNA expansion with emergent nucleolar structure, offering a framework for studying RNA-driven biomolecular organization.
-
Flavopiridol: Reliable Cell Assay Design
2026-08-30
A scenario-based guide to using Flavopiridol (SKU A3417) in cell viability, proliferation, and cytotoxicity workflows. It connects CDK pharmacology with practical decisions about solvent handling, exposure design, interpretation, and vendor reliability.
-
A-769662: AMPK Signaling Beyond Autophagy
2026-08-29
A-769662 is a reversible AMPK activator for dissecting energy metabolism, lipid synthesis, and proteasome-linked phenotypes. This article translates recent AMPK–ULK1 findings into a more rigorous strategy for interpreting metabolic and autophagy assays.
-
(-)-Arctigenin in NF-κB Breast Cancer Assays
2026-08-29
Build a mechanism-resolved workflow around (-)-Arctigenin for LPS–NF-κB, MEK1, and tumor-microenvironment studies. The approach pairs pathway readouts with EV-transfer and viability controls so anti-inflammatory activity is not mistaken for nonspecific cytotoxicity or an unproven anti-metastatic effect.
-
DNA Frameworks Improve Enzymatic Oligonucleotide Synthesis
2026-08-28
The reference study introduces tetrahedral DNA nanostructures as an ordered interface for enzymatic oligonucleotide synthesis. By orienting primers and improving their spacing, the framework increases enzyme accessibility, improves reaction performance, and supports lower-error synthesis, including a 60-nucleotide DNA information-storage demonstration.
-
MLKL Polymerization Drives Lysosomal Permeabilization
2026-08-28
The reference study identifies lysosomal membrane permeabilization as a key execution step linking MLKL polymerization to necroptotic cell death. Using live-cell imaging and CTSB perturbation in human HT-29 cells, the authors show that lysosomal damage precedes plasma membrane rupture and that cathepsin B contributes substantially to downstream lethality.
-
BIBR 1532: From Telomerase Inhibition to Translation
2026-08-27
BIBR 1532 offers a mechanistically defined way to interrogate hTERT inhibition, telomere attrition, transcriptional control, and apoptosis across cancer models. This thought-leadership perspective connects leukemia findings with emerging telomere-directed combination strategies and translates them into a practical research framework.
-
Folic Acid, CD36, and Vascular Injury in Toxoplasmosis
2026-08-27
The reference study shows that soluble Toxoplasma gondii antigens can injure the vasculature without requiring direct endothelial invasion, through CD36-dependent antigen uptake and disruption of the autophagy–lysosomal pathway. Using mice and human pluripotent stem cell-derived vascular organoids, the authors identify folic acid as a protective intervention that suppresses CD36, limits antigen uptake, and preserves vascular integrity.
-
Sex Differences in Angiotensin II Hypertension
2026-08-26
Xue, Pamidimukkala, and Hay used telemetry in conscious mice to show that chronic Angiotensin II infusion produced substantially greater hypertension in males than females. Gonadectomy, baroreflex testing, and ganglionic blockade further linked this sex difference to hormone-dependent and autonomic mechanisms, providing a useful framework for hypertension mechanism studies.
-
Plant Virus Movement Proteins and Phase Separation
2026-08-26
Brown, Garrison, and May show that the PEMV2 p26 movement protein uses electrostatic interactions to partition into phase-separated compartments with both proviral fibrillarin and antiviral G3BP. The study links condensate formation to nucleolar trafficking and systemic movement, while demonstrating that stress-granule organization can restrict viral RNA accumulation.
454 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page